BARCELONA, Spain — The JAK inhibitor upadacitinib can effectively treat systemic sclerosis-associated interstitial lung disease (SSc-ILD), according to results from a new clinical trial. Patients ...

April 27, 2010 (Chicago, Illinois) — In the 1-year planned interim analysis of the CeMyLungs study, both mycophenolate sodium (MPS) and the mTOR inhibitor everolimus were associated with excellent ...

Mycophenolate mofetil (MMF) is an immunosuppressant prodrug that is converted in vivo to mycophenolic acid, which exerts its effects chiefly by inhibiting the de novo synthesis of guanine nucleotides.

The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...

CellCept (mycophenolate mofetil) is not safe to take while pregnant or breastfeeding. Certain factors, including the risks of fetal harm and pregnancy loss, may determine whether you should take the ...

To determine whether sirolimus (SIR) and cyclosporine (CSP) combined with post-transplantation cyclophosphamide (PTCy), after nonmyeloablative or reduced-intensity conditioning unrelated donor ...

Children with frequently relapsing or steroid-dependent nephrotic syndrome had a significantly longer relapse-free survival period with tacrolimus than with mycophenolate mofetil. Relapse-free ...